Luvo Health vs Midi Health

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Luvo Health vs Midi Health: Overview

Choosing between Luvo Health and Midi Health for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Luvo Health offers both semaglutide and tirzepatide at $249/month with a rating of 8.1/10. Midi Health also provides both semaglutide and tirzepatide at $164/month with a 8.6/10 rating.

The price difference of $85/month is significant - Midi Health is the more budget-friendly option, while Luvo Health positions itself as a premium service.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$85/mo
Rating Difference
0.5
Winner
Midi Health
Best For
Budget

Luvo Health

View full Luvo Health review →
Rating
8.1/10
Monthly Price
$249
Medications
semaglutidetirzepatideNAD+sermorelinestradiolenclomiphene

Pros

  • The entire price ladder is published with no intake required, and it shows the per-week equivalent alongside the total: compounded semaglutide injection $249 for 4 weeks ($62/week), tirzepatide injection $339 ($85/week), semaglutide tablets $279 ($70/week) - checked July 28, 2026
  • Longer commitments cut the rate substantially: semaglutide injection falls to $55/week over 12 weeks, $50/week over 24 and $45/week over 52
  • One flat price with no membership fee - medication and provider visits are included rather than billed separately, which is the trap several competitors in this space rely on
  • Branded Ozempic is offered alongside the compounded options at $1,299 for 4 weeks, so you can choose the FDA-approved drug if you would rather not use a compounded preparation
  • 'Compounded medications are not FDA-approved' appears on every single medication page, not just in the site footer
  • The NAD+ page is unusually honest about its own product: 'Clinics sometimes offer NAD+ therapies as part of wellness programs, although evidence for many longevity claims is still emerging.' Almost no competitor in the longevity space concedes that
  • Full refund if a provider disqualifies you for a medical reason before medication is ordered
  • Cancel at any time, with no commitment until a clinician has reviewed your intake
  • The longevity line is cheap relative to the category - NAD+ injection and sermorelin both start at $34/week - and NAD+ comes in three routes: injection, oral drops and nasal spray
  • A genuinely broad catalogue under one provider: weight loss, longevity, hormone replacement (estradiol in five formats), testosterone support (enclomiphene, gonadorelin) and prescription skincare

Cons

  • There is no Trustpilot profile and no BBB record, so there is no independent evidence about what the service is actually like. For a provider asking upwards of $2,000 for a year's supply, that is a real gap
  • The best rates require large upfront commitments. The $45/week semaglutide price means paying $2,327 for 52 weeks, and the refund policy only guarantees money back if a clinician disqualifies you before medication is ordered
  • You are charged for the first month as soon as you complete the intake form, before you know whether you will be approved
  • A separate 'Microdosing' programme is offered. Microdosing GLP-1s is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses
  • The LegitScript certification claimed in the company's partner materials is not evidenced anywhere on its own site
  • Sermorelin is priced and promoted alongside NAD+, but the site does not extend the same 'evidence is still emerging' caveat to it, even though human outcome data for sermorelin in healthy adults is similarly thin
  • No published phone number - support runs through email and your account
  • Ozempic at $1,299 for four weeks is close to full list price, so the branded option is only realistic if you have no insurance route and specifically want the approved drug
  • Compounded semaglutide and tirzepatide are not FDA-approved, and the weight-loss figures associated with these molecules come from trials of the branded products, not compounded versions
Choose Luvo Health

Midi Health

View full Midi Health review →
Rating
8.6/10Better
Monthly Price
$164Cheaper
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s

Pros

  • The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
  • Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
  • Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
  • Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
  • There is no membership fee. You pay for care and medication only
  • Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
  • Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
  • The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
  • Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
  • Available in all 50 states

Cons

  • The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
  • Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
  • Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
  • Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
  • Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
  • Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
  • The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
  • GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Choose Midi Health

Feature-by-feature comparison

FeatureLuvo HealthMidi Health
Monthly Price$249$164
Rating8.1/108.6/10
Medicationssemaglutide, tirzepatide, NAD+, sermorelin, estradiol, enclomiphenecompounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1s
Insurance AcceptedNoYes
Support HoursNot publishedNot published
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedShipped to your door after clinician reviewDiscreet shipping included in every quoted medication price
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyOngoing clinician contact with dose adjustments as the plan evolvesContinued care visits with the same clinician, covered by insurance for qualifying patients
Money-back GuaranteeFull refund if a provider disqualifies you for a medical reason before medication is orderedNone published
Cancellation PolicyCancel at any time via support@luvohealth.com or your account; first month is charged once the intake form is completedNo membership fee and no subscription lock-in; you pay for care and medication only

Which should you choose?

Choose Luvo Health if you:

  • Want more medication options to choose from
  • Value: the entire price ladder is published with no intake required, and it shows the per-week equivalent alongside the total: compounded semaglutide injection $249 for 4 weeks ($62/week), tirzepatide injection $339 ($85/week), semaglutide tablets $279 ($70/week) - checked july 28, 2026

Choose Midi Health if you:

  • Want to save $85/month with a more affordable option
  • Prefer a higher-rated service (8.6/10 vs 8.1/10)
  • Need insurance coverage for your treatment
  • Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)

Website previews

Luvo Health

Luvo Health website

Midi Health

Midi Health website

Our recommendation

Midi Health comes out ahead with a higher rating of 8.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Midi Health

Compare other providers

Compare GLP-1 Brands